- Home
- CRNT vs NBTX Comparison
CRNT vs NBTX Comparison
Compare CRNT & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- NBTX
- Stock Information
- Founded
- CRNT 1996
- NBTX 2003
- Country
- CRNT Israel
- NBTX France
- Employees
- CRNT N/A
- NBTX N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- NBTX Health Care
- Exchange
- CRNT Nasdaq
- NBTX Nasdaq
- Market Cap
- CRNT 207.3M
- NBTX 201.9M
- IPO Year
- CRNT 2000
- NBTX 2020
- Fundamental
- Price
- CRNT $2.71
- NBTX $3.89
- Analyst Decision
- CRNT Strong Buy
- NBTX Strong Buy
- Analyst Count
- CRNT 2
- NBTX 2
- Target Price
- CRNT $4.88
- NBTX $11.50
- AVG Volume (30 Days)
- CRNT 656.6K
- NBTX 7.6K
- Earning Date
- CRNT 11-13-2024
- NBTX 11-26-2024
- Dividend Yield
- CRNT N/A
- NBTX N/A
- EPS Growth
- CRNT N/A
- NBTX N/A
- EPS
- CRNT 0.21
- NBTX N/A
- Revenue
- CRNT $377,617,000.00
- NBTX $45,220,186.00
- Revenue This Year
- CRNT $15.30
- NBTX N/A
- Revenue Next Year
- CRNT $6.42
- NBTX N/A
- P/E Ratio
- CRNT $12.79
- NBTX N/A
- Revenue Growth
- CRNT 13.62
- NBTX 526.17
- 52 Week Low
- CRNT $1.74
- NBTX $3.83
- 52 Week High
- CRNT $3.38
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- CRNT 58.97
- NBTX 40.72
- Support Level
- CRNT $2.33
- NBTX $3.83
- Resistance Level
- CRNT $3.18
- NBTX $4.55
- Average True Range (ATR)
- CRNT 0.15
- NBTX 0.23
- MACD
- CRNT 0.04
- NBTX -0.02
- Stochastic Oscillator
- CRNT 44.71
- NBTX 30.86
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.